Advanced Diagnostic Systems enlists Samsung for Asian sales of BI (breast imaging) system:
This article was originally published in Clinica
Executive Summary
Preston, Washington-based Advanced Diagnostic Systems (ADI) has agreed that Korea's Samsung Corp will distribute its Avera breast imaging system in Asia. Samsung will buy at least 100 systems, which incorporate ADI's proprietary diffractive imaging energy technology, over a four-year period. The technology enables the provision of highly detailed images of the breast without the use of radiation or painful compression. Samsung will take its first deliveries in 2002, initially targeting medical institutions in Korea. ADI profiled the system at this year's Radiological Society of North America annual meeting.
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.